Conzerol zero molluscum contagiosum recalled over manufacturing violations
- Recall date
- November 9, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- DISCOVERY PHARMA LLC recalls Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz…
- Recall number
- D-0261-2023
- FDA classification
- Class II
- Brand / firm
- DISCOVERY PHARMA LLC
- Sold / distributed
- CA, FL, WA
Why it was recalled
CGMP deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
Get recall alerts
Free email alert whenever DISCOVERY PHARMA LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: DISCOVERY PHARMA LLC